File:NS5A inhibitors.svg
From WikiMD's medical encyclopedia
Size of this PNG preview of this SVG file: 349 × 599 pixels. Other resolutions: 140 × 240 pixels | 279 × 480 pixels | 349 × 600 pixels | 447 × 768 pixels | 596 × 1,024 pixels | 1,193 × 2,048 pixels | 512 × 879 pixels.
Original file (SVG file, nominally 512 × 879 pixels, file size: 142 KB)
Summary
| Description |
English: Skeletal formulae of six HCV NS5A inhibitors currently in clinical use (January 2024): daclatasvir, ledipasvir, ombitasvir, elbasvir, velpatasvir, and pibrentasvir. Differences from the basic structure of daclatasvir, the first FDA-approved NS5A inhibitor, are shown in pink. |
| Date | |
| Source | Own work |
| Author | Vaccinationist |
Licensing
|
This image of a simple structural formula is ineligible for copyright and therefore in the public domain, because it consists entirely of information that is common property and contains no original authorship. |  |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 12:01, 4 January 2024 | | 512 × 879 (142 KB) | Vaccinationist | forgot to highlight fluorines in pibrentasvir's benzimidazoles |
File usage
The following page uses this file:
